Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107.2 USD | -0.33% | -0.06% | -2.78% |
04:21pm | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
04-26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
- Stock Market
- Equities
- ABT Stock
- Charts Abbott Laboratories
- Static Chart